R&O - 8/2003
Misuse of Drugs
(Designation) (Amendment No. 5) (Jersey)
Order 2003
Made 5th February 2003
Coming into force 1st
March 2003
THE HEALTH AND SOCIAL SERVICES COMMITTEE, in pursuance of Articles 10 and
25 of the Misuse of Drugs (Jersey) Law 1978,[1] as amended, and after
consultation with the Advisory Council on the Misuse of Drugs, orders as
follows –
1 Amendment of Part 1 of the Schedule
Paragraph (1)(a) of Part I of the Schedule to the Misuse of Drugs (Designation) (Jersey) Order 1989,[2] as amended[3] (referred to in this Order
as “the principal Order”) shall be amended by inserting the
following items in their correct alphabetical positions –
Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine
2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol
2-Amino-1-(3,4-dimethoxyphenyl)ethanol
Benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine
4-Bromo- β,2,5-trimethoxyphenethylamine
N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine
Cyclopropylmethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
Dihydroetorphine
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine
2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine
2-(1,4-Dimethoxy-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine
N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine
2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine
α, α-Dimethyl-3,4-methylenedioxyphenethylamine
α, α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine
Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine
4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine
2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine
2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine
2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine
β -Methoxy-3,4-methylenedioxyphenethylamine
1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine
1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine
2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol
α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine
N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine
β,3,4,5-Tetramethoxyphenethylamine
β,2,5-Trimethoxy-4-methylphenethylamine
α-Methyl-4-(methylthio)phenethylamine (also known as
4-Methylthioamphetamine)
α-Methylphenethylhydroxylamine (also known as N-Hydroxyamphetamine)
2 Amendment
of Part II of the Schedule
Paragraph 1 of Part II of the Schedule to the principal Order shall
be amended by inserting the item “Remifentanil” after the item
“Lofentanil”.
3 Citation
This Order may be cited as
the Misuse of Drugs (Designation) (Amendment No. 5) (Jersey) Order 2003.
M.N. DE LA HAYE
Greffier of the States.